Recent developments in glycine antagonists
- 1 May 2000
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 10 (5), 667-673
- https://doi.org/10.1517/13543776.10.5.667
Abstract
The analysis of patents published on glycine antagonists over the last four years sheds a quite interesting light on a complex picture, revealing the interest towards a few classes of antagonists. A detailed report on these new molecules is presented here.Keywords
This publication has 21 references indexed in Scilit:
- ACEA-1328, AN NMDA RECEPTOR ANTAGONIST, INCREASES THE POTENCY OF MORPHINE AND U50,488H IN THE TAIL FLICK TEST IN MICEPharmacological Research, 1998
- 5-(N-Oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: Novel, Systemically Active and Broad Spectrum Antagonists for NMDA/glycine, AMPA, and Kainate ReceptorsJournal of Medicinal Chemistry, 1997
- Substituted Indole-2-carboxylates as in Vivo Potent Antagonists Acting as the Strychnine-Insensitive Glycine Binding SiteJournal of Medicinal Chemistry, 1997
- Synthesis and biological evaluation of pyrido[2,3-b]pyrazine and pyrido[2,3-b]pyrazine-n-oxide as selective glycine antagonistsBioorganic & Medicinal Chemistry Letters, 1996
- New treatments for acute strokeNature Biotechnology, 1996
- The Glycine Site on the NMDA Receptor: Structure-Activity Relationships and Therapeutic PotentialJournal of Medicinal Chemistry, 1994
- The glycine site of the NMDA receptor — five years onTrends in Pharmacological Sciences, 1993
- The Excitatory Amino Acid Receptors: Their Classes, Pharmacology, and Distinct Properties in the Function of the Central Nervous SystemAnnual Review of Pharmacology and Toxicology, 1989
- Glycine potentiates the NMDA response in cultured mouse brain neuronsNature, 1987
- Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5Nature, 1986